- Home
- GORV vs FGEN Comparison
GORV vs FGEN Comparison
Compare GORV & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- FGEN
- Stock Information
- Founded
- GORV 1976
- FGEN 1993
- Country
- GORV United States
- FGEN United States
- Employees
- GORV N/A
- FGEN N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- GORV Consumer Discretionary
- FGEN Health Care
- Exchange
- GORV Nasdaq
- FGEN Nasdaq
- Market Cap
- GORV 25.3M
- FGEN 33.5M
- IPO Year
- GORV 2015
- FGEN 2014
- Fundamental
- Price
- GORV $0.24
- FGEN $5.57
- Analyst Decision
- GORV Hold
- FGEN Strong Buy
- Analyst Count
- GORV 2
- FGEN 1
- Target Price
- GORV $2.00
- FGEN $250.00
- AVG Volume (30 Days)
- GORV 2.7M
- FGEN 60.6K
- Earning Date
- GORV 08-15-2025
- FGEN 08-05-2025
- Dividend Yield
- GORV N/A
- FGEN N/A
- EPS Growth
- GORV N/A
- FGEN N/A
- EPS
- GORV N/A
- FGEN N/A
- Revenue
- GORV $767,257,000.00
- FGEN $6,996,000.00
- Revenue This Year
- GORV $15.65
- FGEN N/A
- Revenue Next Year
- GORV $20.54
- FGEN N/A
- P/E Ratio
- GORV N/A
- FGEN N/A
- Revenue Growth
- GORV N/A
- FGEN N/A
- 52 Week Low
- GORV $0.13
- FGEN $4.50
- 52 Week High
- GORV $3.56
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- GORV 47.56
- FGEN 37.76
- Support Level
- GORV $0.21
- FGEN $5.37
- Resistance Level
- GORV $0.27
- FGEN $5.73
- Average True Range (ATR)
- GORV 0.02
- FGEN 0.48
- MACD
- GORV -0.00
- FGEN 0.02
- Stochastic Oscillator
- GORV 45.32
- FGEN 28.78
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.